Nexplanon saw its best annual performance ever, growing 17% ex-FX in 2024 and on track to achieve $1 billion in revenue for 2025. International growth was particularly strong in the LAMERA region ...
In November 2011, Nexplanon® was released. Nexplanon has a redesigned inserter intended to minimize deep insertions. The active ingredients in the new device are unchanged; however, Nexplanon ...
Particularly, Women’s Health saw 5% revenue growth. This was driven by a record year for the Nexplanon contraceptive, which saw 12% YoY revenue growth during Q4 to $258 million. This puts it on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback